Editorial Commentary
Rucaparib monotherapy in the heavily pre-treated metastatic castrate-resistant prostate cancer setting: practical considerations and alternate treatment approaches
Rashid K. Sayyid, Rui Bernardino, Julian Chavarriaga, Alexandra Gleave, Ravi Kumar, Neil E. Fleshner